Learn the 3 approved injection sites for personalized semaglutide and tirzepatide, step-by-step vial technique, and rotation schedule to prevent lipodystrophy.
HealthiCare Clinical & Editorial Team
Your first shot can feel like a lot. Most patients expect pain and then barely feel the needle. The harder part is knowing where to inject semaglutide, then drawing the dose without second-guessing the syringe.
This guide covers the recommended sites for personalized semaglutide and tirzepatide, the syringe-based steps for a vial, and a simple rotation plan.
Most injection guides online are written for auto-injector pens, including Wegovy and Zepbound. HealthiCare patients usually receive a vial and syringe, so the handwork matters more here. You still use the same general body areas.
Semaglutide and tirzepatide are subcutaneous injections. The medication goes into the fatty layer just under the skin rather than muscle. Where to inject semaglutide comes down to soft, pinchable tissue you can reach safely.
The abdomen is the easiest place for most patients to start. You can see and pinch the tissue without twisting your body or changing hands mid-shot. The thigh works well when you need another site in the rotation.
The back of the upper arm can work, but it is awkward to reach alone. If you use that site, ask someone trained on your injection steps to help.
Bruising, rashy skin, scar tissue, stretch marks, firm lumps, and dimpled patches all need a pass that week. Stay at least 2 inches away from the navel. If the tissue does not pinch easily, pick another spot.
For weekly GLP-1 injections, clean technique and rotation matter more than chasing a perfect site. FDA labels for semaglutide and tirzepatide name the abdomen, thigh, and upper arm for subcutaneous injection. Where to inject semaglutide should stay within those areas unless your prescriber tells you otherwise.
Those labels also tell patients to rotate injection sites. That is the part people forget once the first few shots feel routine.
The abdomen still wins on practicality for many patients. You can reach it without changing posture, and some patients find it less tender than the thigh. A study of exenatide, another GLP-1 receptor agonist, found comparable bioavailability after subcutaneous injection in the abdomen, arm, and thigh.
That study does not prove identical behavior for every GLP-1 medication. It does support the idea that approved sites can work when technique is sound.
So if you are asking where to inject semaglutide for weight loss, start with the abdomen unless your HealthiCare physician gives you different instructions. Use the thigh or upper arm when you need more rotation space.
Use these steps for a standard insulin syringe and a personalized GLP-1 vial. Read the full sequence before your first injection. It is easier when you are not checking each step with a needle already in your hand.
This is where the pharmacy label matters. You return to a multi-dose vial for later doses, so storage rules are part of the treatment. Follow the label for refrigeration and the beyond-use date because those instructions can vary by formulation, pharmacy, and state requirements.
Your prescription uses milligrams (mg), while the syringe in your hand uses units. That is where people get nervous the first time. A U-100 syringe has 100 units per mL, and this table assumes semaglutide at 5 mg/mL.
Check the vial concentration before you draw. Tirzepatide concentrations vary by pharmacy, and your prescription instructions control the dose you use.
Important — The math above works only for 5 mg/mL semaglutide. If your vial label or prescription lists a different concentration or volume, use your prescription instructions.
A dose change does not change where to inject semaglutide. Stay with the approved sites and update only the syringe volume your prescription gives you.
Rotation protects the tissue under your skin. Repeated shots in one tiny area can leave a firm or rubbery patch called lipohypertrophy. Insulin injection research links that tissue change with less predictable medication absorption, which is why clinicians keep bringing up rotation.
You do not need a new body area every week. Move far enough from the last spot that the same small patch of tissue gets time to rest. A note on where to inject semaglutide each week can prevent accidental repeats.
A clockwise abdomen pattern works well for patients who like a visual cue. Treat the navel as the center of a clock and rotate through spots near 2 o'clock, 10 o'clock, 4 o'clock, and 8 o'clock. Every injection still needs at least 2 inches of distance from the navel.
Then repeat the cycle. You can also stay in the abdomen and rotate through more zones there, as long as you do not return to the exact same spot for at least 2 to 3 weeks.
Tell your HealthiCare physician if you feel a hard lump, a raised area, or an unusually soft patch at an injection site. Stop using that spot until your clinical team reviews it.
These are the errors patients bring up most often during follow-up visits. If you are still unsure where to inject semaglutide, choose a site you can see, clean, and pinch without rushing.
A small welt, mild redness, or light bruising can happen after an injection. Most of the time, those fade within a few hours. Call your physician if the area worsens over 24 to 48 hours or feels warm and swollen.
If a reaction keeps happening in one area, your notes on where to inject semaglutide can help your physician spot a site pattern.
Injection technique is one part of treatment. Patients usually do better when they protect muscle mass with enough protein and use the weekly injection alongside daily nutrition habits. If you are still figuring out what a normal eating pattern on a GLP-1 actually looks like, read that guide with this one.
The clinical differences between semaglutide and tirzepatide also matter if you are choosing between them or considering a switch. If you are just starting, the first steps on GLP-1 medication explains what to expect early on. HealthiCare's personalized semaglutide and tirzepatide are prescribed through board-certified physicians via Beluga Health, available across all 50 states, and dispensed through F&F Pharmacies Inc., a US-based, FDA-registered pharmacy.
Most patients start with the abdomen. The clearest answer to where to inject semaglutide is soft belly tissue at least 2 inches from the navel. Use the outer thigh when you need another rotation site.
Avoid the upper arm unless someone can help with the angle. If you are still unsure where to inject semaglutide, your HealthiCare physician can review your site choice at check-in.
The abdomen and thigh are both listed injection sites for tirzepatide. The abdomen is easier for many patients to see and pinch. The thigh is a useful backup when you are rotating sites.
Do not inject into muscle, the navel, or the 2 inches around it. Skip bruised skin, scars, stretch marks, firm lumps, dimpled tissue, the inner thigh, the front of the thigh, and the area behind the knee.
Use a different spot each week. A 4 to 6 zone pattern across the abdomen and outer thighs works for many patients. Keep a note in your phone so you do not use the same small area again too soon.
After drawing your dose, hold the syringe with the needle pointing up. Tap the barrel so bubbles rise, then press the plunger slightly until a small drop appears at the needle tip. Clearing bubbles helps keep the dose measurement accurate.
This article is for informational purposes only and does not constitute medical advice. HealthiCare's semaglutide and tirzepatide are prescribed by licensed physicians via Beluga Health and dispensed by F&F Pharmacies Inc., a US-based, FDA-registered pharmacy. Always follow the dosing and administration instructions provided with your prescription and consult your prescribing physician with any questions about your individual treatment.
June 29, 2026
